Skip to Main Content
Purpose

Improving performance of healthcare supply chains (HCSCs) remains a priority in low- and middle-income countries (LMICs). Studies highlight the importance of inter-organizational collaboration for superior HCSC performance, a challenge still faced by LMICs due to fragmented practices. Therefore, this study aims to explore the interrelationships between different dimensions of collaboration and supply chain (SC) performance.

Design/methodology/approach

This study built upon an embedded multiple-case design, encompassing both public and private HCSCs with high-level and low-level health facilities in Uganda, a LMIC. Data was collected from documents, archival records and 39 interviews and thematically coded in NVivo.

Findings

Monitoring supply chain flow and stock accumulation provided alerts for stockout and expiration, which are the commonly tracked SC performance indicators in both public and private HCSCs. Significant frequent stockouts occurred in public and low-level health facilities in comparison to the private and high-level ones. Increased presence of collaboration dimensions such as shared benefits, SC relationships, adherence to government guidelines, information technology, inventory management and order processing resulted in higher performance in both public and private HCSCs in Uganda.

Research limitations/implications

Empirical data stems from one country focusing on the main medicines used for prevention and treatment of hemorrhage; further research could include other LMIC settings and medicines to explore how specific dimensions of collaboration affect specific SC performance indicators.

Originality/value

A holistic framework for SC collaboration is proposed to complement fragmented collaboration practices and enable more effective interventions in HCSCs in LMICs.

Improving performance of healthcare supply chains (HCSCs) in low- and middle-income countries (LMICs) remains a priority for national governments and international aid organizations (Ministry of Health, Uganda, 2015; The Global Fund, 2017). The World Health Organization (WHO) estimated that by 2018, 2 billion people [would] have no access to basic medicines, causing a cascade of preventable misery (Chan, 2018:14). The limited availability of medicines disproportionately affects especially LMICs (Olalekan, et al., 2024; Wirtz, et al., 2016).

Despite the considerable investments made to improve HCSCs in LMICs, improvement interventions were not effective resulting in continued low performance (The Global Fund, 2017). Extant studies on LMICs highlight that lack of accurate data on delivery, distribution and storage affects performance of HCSCs (Abdulkadir et al., 2024; Miko and Abbas, 2024) worsened especially by pilferage (Abdulkadir et al., 2024). Mandal and Jha (2018) and later Bak et al. (2023), underlined that HCSCs performance were impacted by the level of collaboration existent in HCSCs. In the case of Uganda, collaboration across HCSCs actors still poses its challenges (Mutebi et al., 2020) including the generic collaboration framework (Namagembe, 2020) and absence of mechanisms to ensure collaboration (Mutebi et al., 2020).

The long-time debate on improving performance of HCSCs in LMICs has been the role of public versus private sector with a view to benchmark across the sectors (Cameron et al., 2009). This approach might have succeeded with the collaborative understanding of performance improvement that Kraiselburd and Yadav (2013) and Stulens et al. (2021) identified as critical for HCSCs in LMIC. On the other hand, Tukamuhabwa et al. (2017) emphasized small-scale, chronic disruptive events, rather than discrete, large-scale catastrophic events as typically a threat to Uganda HCSCs’ performance. Hence, unpacking performance will allow supply chain (SC) collaboration, fine-tuning interventions and hence increasing their effectiveness (Mutebi et al., 2020).

Therefore, this paper aims to develop a framework for SC collaboration in the context of public versus private HCSCs by exploring the following research questions:

RQ1.

What are the dimensions of performance and collaboration within the context of HCSCs in LMICs?

RQ2.

To what extent do associations between the different dimensions of collaboration and performance differ across public and private HCSCs?

Answers to these questions will help to navigate through fragmented collaboration practices, that stand in the way of improving performance of HCSCs in LMICs (Friday et al., 2021).

One of the main healthcare challenges faced by LMICs is hemorrhage, contributing upto 28.4% of maternal deaths in sub-Saharan Africa (Cresswell, et al., 2025). The main medicines used for prevention and treatment of hemorrhage is oxytocin and misoprostol (WHO, 2012), which this study focused on, yet they are often out of stock and expired in Uganda (Ministry of Health, Uganda, 2017a).

Following this introduction, this paper presents a literature review on collaboration and HCSC performance, a methodology outlining an embedded case study in Uganda, followed by findings, analysis, discussion and conclusions.

The definition of performance measures can be a starting point for SC collaboration (Bak et al., 2023; Ralston et al., 2017; Stulens et al., 2021), however, identification of performance measures in the healthcare sector remains yet a challenge (Ramanathan and Ramanathan, 2011) as performance measures may differ across different levels and different contexts of HCSCs (Bak et al., 2023). Therefore, performance measures need to be specified at different levels in the SC (Simchi-Levi et al., 2009).

Stockout and stock expiration are commonly used performance indicators for HCSCs in LMICs (The Global Fund, 2017; Kumar and Das, 2023). Whereby, stockout occurs when there is no medicine left in the health facility (HF) store for a minimum period of one day (Ministry of Health, Uganda, 2017b). Stock expiration occurs beyond the expiry date, that is:

the date placed on the container or labels of a medical product designating the time during which it is expected to remain within established shelf-life specifications if stored under defined conditions, and after which it should not be used (WHO, 2022:305).

Thus, decrease in stock expiration is an important element of SC performance and can motivate enhanced collaboration (Kwon and Kim, 2018).

In comparison, stock accumulation is greatly influenced by ordering practices (Mohamed and Huynh, 2023) where more frequent ordering allows to keep stocks within set maximum levels above which stock is more likely to expire before use (Simchi-Levi et al., 2009). Hence, stock accumulation provides an alert, signaling its risk for future stock expiration in HCSCs. On the other hand, health service providers seek […] reliable uninterrupted supplies (Kwon and Kim, 2018:143), whereby LMICs rely highly on global HCSCs for medicines (Onyango, 2024; Stulens et al., 2021). Disruption in flow of medicines can be a major challenge for the LMICs (Simchi-Levi et al., 2009; Stulens et al., 2021), for example during COVID-19 pandemic (Arji et al., 2023; Olalekan, et al., 2024; and Onyango, 2024). Disruptions may be due to insufficient financing (Kraiselburd and Yadav, 2013; Privett and Gonsalvez, 2014; Yadav, 2015), and complexity of multi-level HCSCs within the country particularly the challenge of last mile (Jahre, et al., 2012; Yadav, 2015). Hence, supply chain (SC) flow – especially of information, funds and products can provide an alert, to signal the risk of future stockouts or stock expiration in HCSCs.

Collaboration in HCSCs lags behind other sectors due to the investments required and the challenges associated with assessing benefits for its SC members (Friday, et al., 2021), yet improved collaboration would overcome uncertainties inherent in complex HCSCs (Stulens et al., 2021). To assess SC collaboration; strategy, structure, systems and processes have been utilized (Rodrigues et al., 2004; Romule et al., 2020). Strategy is defined as the alternate ways in which organizations define their product-market domains(Miles et al., 1978:546). In the context of collaboration, this involves the alignment of each player’s business goals with those of the collaboration (Angerhofer and Angelides, 2006). Structure refers to “patterned regularity that is reproduced as its members interact and communicate about their interactions to coordinate actions and sustain the state of being organized” (Wagner, 2025:1854). Systems are defined as complex entities with clearly delineated boundaries, comprising interconnected components that interact with one another (Alvargonzález, 2019). Process on the other hand is defined as “a set of logically related tasks performed to achieve a defined business outcome” (Vollmann, 1996, p. 60).

2.1.1 Strategies for collaboration in healthcare supply chains

Collaboration in supply chains involve inter-organizational cooperation and coordination (Gulati et al., 2012) where two or more autonomous SC members jointly plan and execute operations (Cao and Zhang, 2011). However, for HCSCs in LMICs cooperation is underdeveloped as evidenced by the absence of or non-commitment to strategic plans and/or goals (The Global Fund, 2017; Yadav, 2015). According to Mandal and Jha (2018:2668) the benefits of SC collaboration can be realized fully when every key SC entity is ready to cooperate. Cooperation happens when all SC members agree on shared goals and benefits, as well as their responsibilities (Ralston et al., 2017). Therefore, shared goals (Liu et al., 2022) and benefits (Mandal and Jha, 2018) are strategies for SC collaboration impacting resource allocation in terms of finances and budgeting and SC performance (Romule et al., 2020). In a resource constrained setting, cost sharing is a key responsibility of collaborators and according to the Ministry of Finance, Planning, and Economic Development, Uganda (2024), a key government strategy is to allocate a dedicated budget to the central medical stores for all public HFs. This practice is called “contribution of resources.”

Therefore, this paper explores the three extant strategies for collaboration applicable to HCSCs in LMICs – shared goals, contribution of resources and shared benefits.

2.1.2 Structures for collaboration in healthcare supply chains

The overall performance of HCSCs is enabled through the coordination of [several] business functions (Vijayasarathy, 2010: 492). However, a key weakness of HCSCs in LMICs is absence and inefficiency of coordination structures yet stakeholders hold divergent objectives (Yadav, 2015). This is exemplified by The Global Fund (2017) report that in most countries, governance structures are ineffective at resolving supply chain interventions. Lack of coordination leads to incomplete demand information and lack of shipment visibility, resulting in excessive inventory and waste, due to stock expiration (Privett and Gonsalvez, 2014).

This gap highlights the necessity for formal mechanisms to foster SC collaboration. Extant literature suggests four foundational structures: Supply chain relationships – the broad variety of contractual arrangements that form the basis for collaboration between independent organizations (Kraiselburd and Yadav, 2013); Coordinating institutions – dedicated groups or individuals tasked with extemporaneously troubleshooting and solving emerging challenges (Gulati et al., 2012); Coordinating committees – formal committees vital for engaging multiple stakeholders in long-term agendas (Kraiselburd and Yadav, 2013); and government guidelines – the formal and informal rules and policies set by government to govern supply chain operations, identified as necessary to provide a framework for collaboration (Gulati et al., 2012; Mandal and Jha, 2018; Chen et al., 2020).

2.1.3 Systems for collaboration in healthcare supply chains

The utilization of information systems and technology to facilitate data capture, analysis and information sharing has been demonstrated to enhance SC performance (Angerhofer and Angelides, 2006; Simchi-Levi et al., 2009). Extant studies have highlighted that there is paucity of accurate data on delivery, distribution and storage (Abdulkadir et al., 2024). Furthermore, deficiencies in SC performance measurement compromise the performance of HCSCs in LMICs (Kraiselburd and Yadav, 2013; Miko and Abbas, 2024; Privett and Gonsalvez, 2014; and Yadav, 2015). The creation of an integrated performance measurement system to monitor SC performance has been proven vital in the healthcare context in Morocco, a low-middle income country (Chorfi et al., 2018).

Based on the foregoing, this paper explores information systems including information technology and information sharing, as well as SC performance measurement as the systems for healthcare SC collaboration in LMICs.

2.1.4 Collaboration processes in healthcare supply chains

Organizations are integrated into a SC through inter-organizational processes (Lambert et al., 2005), a key ingredient for SC integration (Flynn et al., 2010). The first process framework proposed for SC collaboration is the Supply Chain Operations Reference (SCOR) model (Simchi-Levi et al., 2009). The SCOR model provides a good benchmark for industries to compare and assess their SC processes including Plan, Source, Deliver and Return (Lockamy and McCormack, 2004).

In the context of HCSCs, collaboration processes between key stakeholders have been shown to mitigate stockouts (Friday et al., 2021). In relation to planning, Abdulkadir et al. (2024) contended that demand-driven decision-making informed by real data would enhance the provision of medicines to patients in Nigeria. Regarding sourcing, Kessy et al. (2024) argued that fostering close interactions between suppliers and HFs would engender trust in Tanzania. Regarding delivery, the study by Kessy et al. (2024) revealed that the main difference between public and private medical commodities supply chains is in the extent to which the different steps in the process are standardized. Finally, regarding return processes, Ribeiro et al. (2021) highlighted the absence of standardized processes for reverse flows of hospitals in Brazil and the associated negative financial and environmental consequences. The interdependent nature of the four processes is identified as the determining factor for SC performance (Angerhofer and Angelides, 2006).

Therefore, given its demonstrated applicability in HCSCs in LMIC, this study adopted the dimensions of the SCOR model to deepen the process dimension of collaboration.

Overall, this review of literature reveals that a holistic assessment of all collaboration (sub-) dimensions is underdeveloped in the extant literature, and even more so in the context of HCSCs in LMICs. Our empirical study is grounded upon such holistic approach as set out in Table 1.

Table 1

Supporting literature of key variables of the research model

Key variablesDimensionsAuthors
Supply chain performanceUninterrupted SC flow (of products, finances and decisions)Flynn et al. (2010); Kwon and Kim (2018); Ralston et al. (2017); and Yadav (2015) 
StockoutsKumar and Das (2023); Simchi-Levi et al. (2009); and Stulens et al. (2021) 
Stock accumulationMohamed and Huynh (2023); Simchi-Levi et al. (2009) 
Stock expirationBak et al. (2023); Kwon and Kim (2018) 
Strategies for SC collaborationShared goalsGulati et al. (2012); Liu et al. (2022); Ramanathan and Ramanathan (2011); Rodrigues et al. (2004); Romule et al. (2020) 
Contribution of resources (finances and budgeting)Romule et al. (2020); Yadav, 2015 
Shared benefitsGulati et al. (2012); Mandal and Jha (2018); and Romule et al. (2020) 
Structures for SC collaborationSupply chain relationshipsGulati et al. (2012); and Mandal and Jha (2018) 
Coordinating institutionsChen et al. (2020); Gulati et al. (2012); and Privett and Gonsalvez (2014) 
Coordinating committeesGulati et al. (2012); Kraiselburd and Yadav, 2013; Privett and Gonsalvez (2014); Vijayasarathy (2010); and Yadav (2015) 
Government guidelinesChen et al. (2020); and Holt and Ghobadian (2009) 
Systems for SC collaborationInformation systems (information technology and information sharing)Angerhofer and Angelides (2006); Arji et al. (2023); Kraiselburd and Yadav (2013); Privett and Gonsalvez (2014); Ralston et al. (2017); and Yadav (2015) 
Performance measurement system joint KPIs, joint performance monitoring)Chorfi et al. (2018); Kraiselburd and Yadav (2013) 
SC collaboration processesPlan (demand forecasting and supply planning) Source (procurement) Source (warehousing and inventory management) Deliver (order processing) Deliver (distribution to last mile) Return (redistribution)Abdulkadir et al. (2024); Asrol et al., 2021; Kessy et al. (2024); Lambert et al. (2005); Lockamy and McCormack (2004); Ribeiro et al. (2021); Simchi-Levi et al. (2009) 
Source(s): Table created by authors

Themes from literature review were fine-tuned through theory-data iterations to enable consideration of all potential explanations of low performance of HCSCs (Eisenhardt, 1989). Figure 1 shows the research framework that guided data gathering, analyses and presentation of results.

Figure 1
A diagram illustrating supply chain collaboration strategies, structures, systems, and processes with a focus on performance outcomes.The diagram presents a structured overview of supply chain collaboration, divided into four main sections: Strategies for S C collaboration includes shared goals, contribution of resources, and shared benefits. Structures for S C collaboration outlines supply chain relationships, coordinating institutions, committees, and government guidelines. Systems for S C collaboration covers information systems with subcategories for Information Technology and information sharing, as well as S C performance measurement with joint K P I s and performance monitoring. S C collaboration processes detail planning, sourcing, delivery, and return logistics. Arrows connect these sections to the outcome of S C performance, which features uninterrupted supply chain flow, reduced stockouts, stock accumulation, and expiration.

Research framework collaboration and performance of healthcare supply chains

Source: Figure created by authors

Figure 1
A diagram illustrating supply chain collaboration strategies, structures, systems, and processes with a focus on performance outcomes.The diagram presents a structured overview of supply chain collaboration, divided into four main sections: Strategies for S C collaboration includes shared goals, contribution of resources, and shared benefits. Structures for S C collaboration outlines supply chain relationships, coordinating institutions, committees, and government guidelines. Systems for S C collaboration covers information systems with subcategories for Information Technology and information sharing, as well as S C performance measurement with joint K P I s and performance monitoring. S C collaboration processes detail planning, sourcing, delivery, and return logistics. Arrows connect these sections to the outcome of S C performance, which features uninterrupted supply chain flow, reduced stockouts, stock accumulation, and expiration.

Research framework collaboration and performance of healthcare supply chains

Source: Figure created by authors

Close modal

This research is grounded upon an embedded multi-case study design to explore a contemporary phenomenon within its real-life context; and answering “why” and “how” questions (Yin, 2014), in this case the functioning of HCSCs. The study’s unit of analysis is the supply chain. Interviewees, acting as organizational keepers, provided information focused on their organizations’ roles within the supply chain, with data collected from diverse SC members. The multi-case study design enables theoretical replication and fosters in-depth understanding of the HCSCs, by generating findings specific to sub-cases, permitting within- and across-case comparisons across different HCSC layers and types. This approach empirically grounds findings and maximizes construct validity through diverse inquiry and multiple sources of evidence (Eisenhardt, 1989).

According to Ministry of Finance, Planning, and Economic Development, Uganda (2024) and Uganda Bureau of Statistics (2024), Uganda is a low-income country with a government per capita medical supply budget of USD4.01 – far below the USD13-25 estimated as the minimum requirement for LMICs (Wirtz, et al., 2016). Expiration of medicines albeit the constrained budget and recurring stockouts indicates systemic medicine SC challenges. Therefore, Uganda serves as a typical case (Yin, 2014) due to its pronounced budgetary constraints and ineffective HCSCs, challenges experienced by many LMICs (The Global Fund, 2017). By examining Uganda’s context, this study provides insights into systemic challenges in HCSCs that are transferable to other LMICs. While contextual differences may limit direct generalizability, the findings offer a framework applicable across LMICs.

In Uganda, the MOH is responsible for policy direction, while National Drug Authority is responsible for regulation. National Medical Stores (NMS) is the lead supplier to public HFs (Ministry of Health, Uganda, 1993), whereas Joint Medical Store (JMS) and several other private firms are engaged in the supply, manufacture, warehousing, distribution use and dispensing of pharmaceuticals. Uganda imports over 90% of its medicines (Rugumambaju and Kutyabami, 2010). Health Facilities owned by the Government (public) or privately can be classified into low level (HCI to HCIII) and high level (HCIV, General Hospital, Regional Referral Hospital and National Referral Hospital) (Ministry of Health, Uganda, 2016). Figure 2 provides an illustration of the HCSCs studied.

Figure 2
A flowchart illustrating two cases of health care supply chains, showing connections between suppliers, manufacturers, and health facilities, with annotations on key entities involved.The image presents a flowchart outlining two distinct cases of health care supply chains. Case 1 details a public supply chain involving entities such as the Healthcare Supply Chain (H C S C), National Medical Stores (N M S), the Ministry of Health (M O H), and various partners like the United Nations Population Fund (U N F P A) and the World Bank (W B). It shows the process from suppliers to manufacturers and includes a regional coordination office leading to government high-level and low-level health facilities. Case 2 outlines a private supply chain involving partners like Joint Medical Store (J M S) and similar agencies. The flowchart specifies pathways for healthcare supplies and orders, including transit storage at district stores. Relevant abbreviations and their explanations are provided at the bottom, detailing terms such as HF for health facilities, H C 3 for Health Facility level three, and H C 4 for Health Facility level four.

An illustration of the supply chains studied

Source: Figure created by authors

Figure 2
A flowchart illustrating two cases of health care supply chains, showing connections between suppliers, manufacturers, and health facilities, with annotations on key entities involved.The image presents a flowchart outlining two distinct cases of health care supply chains. Case 1 details a public supply chain involving entities such as the Healthcare Supply Chain (H C S C), National Medical Stores (N M S), the Ministry of Health (M O H), and various partners like the United Nations Population Fund (U N F P A) and the World Bank (W B). It shows the process from suppliers to manufacturers and includes a regional coordination office leading to government high-level and low-level health facilities. Case 2 outlines a private supply chain involving partners like Joint Medical Store (J M S) and similar agencies. The flowchart specifies pathways for healthcare supplies and orders, including transit storage at district stores. Relevant abbreviations and their explanations are provided at the bottom, detailing terms such as HF for health facilities, H C 3 for Health Facility level three, and H C 4 for Health Facility level four.

An illustration of the supply chains studied

Source: Figure created by authors

Close modal

Cases were selected following replication logic to provide examples of polar types (Eisenhardt, 1989, p. 537). To appreciate the variation of context along the SC, this study compared public and private HCSCs as well as high-level vs low-level HFs.

Data collected from documentation, archival records and 39 interviews informed the study. Data on stockout and expiration of medicines were extracted from bimonthly MOH stock status reports and annual Auditor General’s reports to rate supply chain performance. Interviewees suggested informative documents (reports and strategic plans) which were added. Face-to-face interviews in English followed an interview guide (see  Appendix 1) and were audio recorded and transcribed verbatim. Interviewees included officers at lead supply agencies (NMS and JMS), MOH, development agencies, districts and HFs (see  Appendix 2).

Documents and interview transcripts were uploaded into NVivo and coded thematically. Following theory-data iterations (Eisenhardt, 1989), themes included strategies for SC collaboration, structures for SC collaboration, systems for SC collaboration and SC collaboration processes as well as the performance measures of SC flow, stockout, stock accumulation and stock expiration (see  Appendix 3).

Drawing on Yin (2014), this study adopted several strategies to enhance validity and reliability. Construct validity was ensured using multiple data sources. Internal and external validity were enhanced by utilizing an embedded multiple-case study design, employing replication logic and limiting generalization to theory and context (Yin, 2014). Finally, a case study protocol ensured reliability, per Yin (2014)’s recommendations.

Reliability of content analysis was assessed for stability and reproducibility using intercoder reliability (ICR), the extent to which two or more coders agree on the coding of a given text (Campbell et al., 2013). Cohen’s kappa (Cohen, 1960) Cohen (1960) was used to examine ICR (MacPhail et al., 2016). Consensus was built on the coding approach through two rounds of independent coding of same text by the three investigators and joint assessment of ICR by the team (MacPhail et al., 2016).

Antecedent variables, assessed for presence on a 4-point Likert scale (1=absent, 4=very high), intentionally excluded a neutral option to force determination (Chyung et al., 2017). Where applicable, performance was similarly rated (1=very poor, 4=very good). The first author assigned Likert scale scores which were reviewed by the coauthors. Potential discrepancies were debated by the author team and led to updating of some scores. Association was then derived from absolute score difference between presence of dimensions and performance rating (0–3): (0 strongly associated), (1 moderately), (2 weakly), (3 not associated). Antecedent variables exhibiting an absolute score difference of two or less were deemed to be impactful on SC performance.

This section details performance dimensions. Stockout and stock expiration were widely recognized SC performance measures in the cases. Stockout was a commonly used SC performance measure and a major challenge for public HFs. [W]e have had stockouts of especially oxytocin and it really affected us very much. […] It was from November of last year to around February of this year (KII Public HCIV). In addition, national stock status reports indicated frequent stockouts in public and low-level HFs compared to private and high-level ones, respectively. Structured data on stock expiration (location, quantity, and value) were scarce, despite self-reported incidences. Unlike stockout, expiration data were disaggregated only by HF level, yet KIIs revealed that expiration was rare in the private sector; we have not had any expirations (KII Private Hospital), another interviewee noting [n]o, those ones do not expire (KII Private HCIII).

On the other hand, stock accumulation and SC flow were less recognized SC performance measures. On SC flow, the Auditor General’s report of February 2021 identified disruptions in flow of funds intended to finance medicines for public HFs. This was corroborated by a national officer who claimed that [w]e don’t have visibility into how much money NMS was allocated to procure a specific product. Yet interviews could not pinpoint where and how disruptions occurred. Stock accumulation was only noted in extreme cases for example, misoprostol we always have much even that last week I gave some to the municipal council. (KII Public Hospital) and not always a challenge under the public HCSC because it mitigated against stockouts, as an interviewee suggested [i]t (stock accumulation) cannot be because it is always shared with other facilities. (KII District Officer). In the private HFs stock accumulation was sometimes deliberate to prevent stockouts. We order a large quantity of oxytocin, so it is always there (KII Private Hospital). Table 2 shows the applicability of SC performance dimensions in public versus private HCSCs.

Table 2

Applicability of performance indicators in different contexts

Performance measurement scores
Dimensions of performancePublic high-level health facilityPublic low-level health facilityPrivate high-level health facilityPrivate low-level health facility
Supply chain flowPerformance reports lacked this data and interviewees could not readily pinpoint where and how disruptions to supply chain flow occur
Stockout2143
Stock accumulationPerformance reports lacked this data and interviewees could not readily assess stock accumulation due to the challenge of defining what quantity constitutes a ‘month of stock’
Stock expiration2144
Source(s): Table created by authors

Therefore, the performance of HCSCs in Uganda was measured by two final SC performance outcomes 1) stockout and 2) stock expiration. In contrast, the other SC performance indicators, namely 1) SC flow and 2) stock accumulation were not yet widely applied.

In this section, we provide empirical evidence of each dimension of SC collaboration. Table 3 presents the degree to which dimensions of SC collaboration were present in public versus private HCSCs, whereas Table 4 shows the resultant framework.

Table 3

Degree of presence of the subdimensions of collaboration

Measurement scores
Dimensions of healthcare supply chain collaborationSubdimensions of collaborationPublic high-level health facilityPublic low-level health facilityPrivate high-level health facilityPrivate low-level health facility
Strategies for SC collaborationShared goals2222
Contribution of resources (budgeting and financing)3311
Shared benefits (incentives)1144
Structures for SC collaborationSupply chain relationships2232
Coordinating institutions2211
Coordinating committees2111
Government guidelines on clinical use1133
Government guidelines on logistics management2233
Government guidelines on services provided2233
Systems for SC collaborationInformation technology2131
Information sharing1121
Joint key performance indicators (KPIs)2111
Joint performance monitoring2111
SC collaboration processesPlanning2222
Source (procurement)3233
Source (warehousing and inventory management)2233
Product delivery (order processing)2144
Product delivery (distribution to last mile)4444
Product return (redistribution)4422
Source(s): Table created by authors
Table 4

Framework for supply chain collaboration within the context of public versus private healthcare supply chains in LMICs

Impactful subdimensions of collaboration
Dimension of healthcare supply chain collaborationPublic healthcare supply chain onlyPrivate healthcare supply chain onlyBoth public and private healthcare supply chainsLess impactful subdimensions of collaboration
Strategies for SC collaborationShared goalsShared benefitsContribution of resources
Structures for SC collaborationCoordinating institutionsSupply chain relationships
Coordinating committeesGovernment guidelines
Systems for SC collaborationInformation sharingInformation technology
Joint KPIs
Joint performance monitoring
SC collaboration processesPlanning (demand forecast and supply plan)Source (procurement)Source (warehousing and inventory management)Return (redistribution of excess stock)
Delivery (last mile distribution)Delivery (order processing)
SC performance indicators1) Supply chain flow, 2) stockout, 3) stock accumulation, 4) stock expiration
Source(s): Table created by authors

4.2.1 Strategies for supply chain collaboration

Despite presence of a national pharmaceutical sector strategic plan (Ministry of Health, Uganda, 2015), it did not result in shared goals among SC members as noted by the district official [w]e just show them the dangers and we show them how to utilize that outcome, but it is not in the district plan (KII District Official). Similarly, the private sector was not keen on strategic plans noting that [i]t (strategic plan) is there with the administration (KII Private Hosp).

Regarding the contribution of resources, public HCSC funds were paid directly to the public lead supply agency, NMS (Ministry of Finance, Planning, and Economic Development, Uganda, 2024). In contrast, private HFs mainly relied on facility generated user fees without first contributing the funds to a pool; on the side of what (they) sell there is no challenge, on the side of the free commodities there is not any indication of source of funding– (KII National, JMS).

On shared benefits, none accrued from appropriate performance in public HFs because (t)he incentive system is not given according to performance like avoiding stockouts. […] the incentives are about you reporting to the work for the 30 days (KII National). In contrast, there was a strong shared financial incentive for good performance in the private HCSCs which relied on user fees. Consequently, the private lead SC agency, JMS ensured that medicines were always available; [f]or the one we sell, we do not face any challenge because for us we do cost recovery. (KII National, JMS).

Based on the findings of cross-case analyses shared benefits were strongly associated with SC performance in both public and private healthcare settings. On the other hand, shared goals were only strongly associated with performance in public HCSCs, whereas the contribution of resources was not associated with performance in either HCSC (see  Appendix 4).

4.2.2 Structures for supply chain collaboration

Supply chain relationships in public HCSCs were not favorable but driven by mandate of the lead supply agency (Ministry of Health, Uganda, 1993), and communication was only out of necessity. [W]ith medical stores […], there is nothing much apart from the deliveries. […] the only time they communicate is when the order has delayed (KII Public HCIII). In contrast, SC relationships were more favorable in the private SC which relied on formal contracts and long-term supply agreements. [W]e have a very good relationship with them because they can give this institution a credit […] we always tell them what we need, and their management collaborates (KII Private Hospital).

Coordinating institutions and committees in both public and private HCSCs were underdeveloped, lacking dedicated technical staff for medicines. Supply chain management was an additional, on-the-job role. Consequently, an interviewee noted that [c]oordination is a challenge when you go down to the districts; they don’t have someone whose main obligation is logistics (KII National, MOH). Coordinating committees were undermined by duplication and nonattendance. Besides, the official Technical Working Group (Ministry of Health, Uganda, 2015) was another Commodity Security Group which was also undermined by nonattendance. [I]n the meeting we invite over 70 people but 30 regularly attend (KII National, QPPU). The private lead supply agency, JMS concurred that [t]he RH meetings are so many […], so some of those might not yield much because some stakeholders may not be involved. (KII National, JMS).

At HF level, many public high-level HFs lacked functional Medicines and Therapeutics Committees (MTCs) to ensure that allocated budgets are used to procure medicines, with an interviewee stating that there was no functional MTCs (KII Public Hospital). Low level public HFs received a predetermined kit and thus had no MTCs. Similarly, private HFs either lacked functional MTCs or they were on and off. [W]e have a therapeutic committee, but it has spells of activity and spells of non-activity especially during the Covid period (KII Private Hospital).

Public HFs showed lower adherence to government guidelines, such as those for dispensing misoprostol. This led to inconsistent use of alternative medicines (misoprostol versus oxytocin) and fueled misconceptions about misoprostol’s use in illegal abortions. There is an abuse of misoprostol by schoolgirls which affects the availability of the drug (KII District Official). This undermined demand forecasting in the public HFs. Similarly, the logistics management guidelines (Ministry of Health, Uganda, 2017c) were not adhered to under the public HCSC. For instance, the guidelines on accepting donations were disregarded, which resulted in their expiration:

They did not follow that guideline [on donations], there was no expressed need from the recipient - regional referral hospitals. […] it was pushed a lot, but now they have expired – KII Public Hospital.

Further, the range of services provided by public lower-level facilities were not in tandem with medicines supplied They just tend to refer even simple cases which can be managed at those health centers, so we end up serving an overwhelming number of patients– KII Public Hospital.

Cross-case analyses showed that formal SC relationships and adherence to government guidelines were strongly associated with performance in both public and private HCSCs. However, coordinating institutions and committees were only strongly associated with performance in public HCSCs (see  Appendix 5).

4.2.3 Systems for supply chain collaboration

The paucity of information sharing between HFs and the lead SC agencies was attributable to technological limitations in both public and private HCSCs. Information technology initiatives in the public HCSCs were dependent on stand-alone donor-funded electronic Logistics Management Information Systems (eLMIS) tools. These initiatives encountered difficulties with integration due to the presence of varying systems, inadequate infrastructure and high internet costs:

[A]ll the time you find there is no data, the network is on and off. At times I am forced to wake up at night during the ordering time or early morning by 5 am I am here when majority of the people are not here (because you want to find internet) (KII District).

Consequently, stock levels were not monitored at the central level. [I] want to know what exactly is happening at facility level, (KII National, QPPU).

On the other hand, several private hospitals used Enterprise Resource Planning (ERP) Systems enabling visibility. [T]hey can be seeing the patients who are coming to the pharmacy in the system (KII Private Hospital). Surprisingly, private high-level HFs which did not have ERP systems still used paper records effectively:

We use the dispensing logbooks […]at the end of the day, we get totals in the dispensing logbooks, and we balance it to see how much one has consumed, how much was ordered from the store and how much is remaining in the stock cards (KII Private Hospital).

In addition to technological limitations, information sharing was not seen as a common practice in both public and private HCSCs. For instance, members of staff at one private high-level HF were uncertain as to why they should share information with suppliers; for the medicine they do not have any hand in contributing for us, why should we give them a report?. Similarly, lead agency stock status reports were irregular with one interviewee claiming that [n]ational level data is not readily available. […] You have to wait for somebody to send you a mail once in a while (KII National Officer). Further, the reports lacked information on allocation of funds, status of procurement and inventory pipeline information as stated by one interviewee that [w]e don’t have visibility into how much money NMS has allocated to procure a specific product. Neither do we have information on how much is going to be delivered and when. (KII National Officer).

There was minimal alignment behind joint KPIs for public and private HFs. The National Pharmaceutical Sector Strategic Plan (NPSSP) included KPIs agreed among SC members (Ministry of Health, Uganda, 2015). However, the Supervision Performance Assessment and Recognition Strategy (SPARS) was popular among public and private HFs for SC performance measurement but used a different set of KPIs (Ladwar et al., 2021). Further, the MOH annual health sector performance report used three KPIs different from those in SPARS and the NPSSP (Ministry of Health, Uganda, 2017b) and perceived as externally imposed by the lead SC agency; I don’t see much (value) because, for instance when you calculate their order fulfillment rate, it’s like for the wrong consumption but it means much to them because it can maybe help them improve their performance. But for us here, I don’t think so (KII Public Hospital). Consequently, joint SC performance review (Ministry of Health, Uganda, 2020) was ineffective because the indicators used were not the same as those in the NPSSP. An interviewee summarized the situation as … we spend time developing a plan and we don’t have enough time to see if we are on track (KII National Officer).

Cross-case analyses showed that Information Technology was strongly associated with performance in both public and private HCSCs. Conversely, information sharing, joint KPIs and joint performance monitoring were strongly associated with SC performance only in public but not private healthcare settings (see  Appendix 6).

4.2.4 Supply chain collaboration processes

Guided by the SCOR model, this section shows how the SC collaboration processes influenced performance of public versus private HCSCs in Uganda.

Demand forecasting was inadequate both in public and private HCSCs. Particularly, public HFs faced fixed budget allocation and lacked an evidence-based approach; [t]hey really didn’t use a scientific approach to do their forecasting, so it was more based on estimation and haggling here my department needs this (KII Public Hospital). Whereas low-level public HFs with predetermined medicines kits were more affected [u]sually, the cheapest means is to endure with whatever it is, if patients can buy those who are severely sick, they buy until the next supply (KII Public HCIII). In parallel, private HFs suffered bullwhip effect; […] you never know when they have money to come and procure. I have no guarantee that they will come (KII Private Warehouse JMS).

Interestingly, the internal procurement processes were effective in both public and private HCSCs under the lead agencies (NMS and JMS, respectively) an interviewee noted:

[d]onor A, we use our own procurement procedures, donor B, also uses its own, government also uses its own PPDA, so they are different. And it can never be uniform because these are different agencies. (KII National).

In this context the warehousing was found adequate under both public and private HCSCs, except for private cold chain capacity being limited. Hence, when JMS experienced oxytocin shortages, alternative suppliers often lacked stock due to limited cold chain storage capacity. An interviewee stated that:

JMS did not have the medicine for almost close to six months. […] Yet most of the businesspeople do not invest their money in the cold chain products because they are not easy to keep and manage. (KII Private Hospital).

Nevertheless, private HFs still obtained oxytocin from alternative sources. There is also a pharmacy in town which has a fridge. We can always get the medicine from there in case of any shortages (KII Private Hospital).

On inventory management, private HCSCs were relatively better; [w]e check on the stock levels monthly […] we do physical counting and also do weekly checkups depending on the consumption.– KII private HCIII. In contrast, the public HCSC delivered short shelf medicines suggesting suboptimal inventory management; It (oxytocin) was delivered by then it had three months shelf life, and the quantity was even more than what we needed. It was pushed (KII Public Hospital). Further, public HCSCs suffered pilferage:

if you are not really so strict with it[misoprostol], there these people in town who really want to have access [to] it from hospitals because people use it for illegal abortion (KII Public Hospital).

Regarding order processing, public low-level HFs received predetermined kits decided at the beginning of each planning cycle but perceived by staff as a push logistics system; [s]ometimes we get more than what we need and sometimes we even have to give to some other health units (KII Public HCIII). Similarly, public high-level HFs received unsolicited donated medicines; [i]t was a donation; it came in a lot […] they just decided to divide this among the seventeen regional referrals. We didn’t order, they just received them, so they were pushed (KII Public Hosp). In contrast, deliveries to the private HFs were in line with orders placed for both high- and low-level private HFs.

Considering, last mile distribution, it was well conducted in both cases, public and private HCSCs using Third-Party Logistics (3PL) without noticeable delays; […] the one that they gave the contract is working well, they are ok, so far there is no challenge (KII Public District).

Redistribution being common in public HCSCs enabled low-level HFs (HCII) to provide maternal care whereas higher level HFs were inaccessible, yet human resource capacity existed at low-level HFs (HCII); [to] avoid any shortages, HCIIIs should factor in supplies of HCIIs […] so that when they receive, they can also supply enough supplies to the HCIIs (KII Public DHO). On the other hand, redistribution was rare in the private HFs:

[i]t (redistribution) is rare but sometimes we do. But ours is very rare. Because we stock for two weeks, it is very rare. But these other drugs (like ARTs, TB medicines, etc.) we can give another facility (KII Private Hospital).

Cross-case analyses on the SCOR processes revealed varied associations. Source (warehousing & inventory management) and product delivery (order processing) were strongly associated with performance in both public and private HCSCs. Planning (demand forecast and supply plan) was strongly associated with performance of high-level public and private HFs. Conversely, source (procurement) and product delivery (last mile distribution) were strongly associated with performance of only the private HCSC, whereas product return (redistribution) was not strongly associated with the performance of any of the HCSCs (see  Appendix 7).

The above findings, along the different dimensions of collaboration are summarized in the proposed framework for SC collaboration in LMIC public and private HCSCs (see Table 4). The integrative and holistic nature of our framework, associating precise facets of collaboration with SC performance allows to counter fragmented collaboration practices.

The study findings indicated that monitoring SC flow and stock accumulation may result in alerts regarding the more tracked SC performance – indicators stockout and stock expiration. However, as the study findings highlighted, this practice remains rather underdeveloped in both public and private HCSCs. Similarly, recent academic discussions highlighted the importance of monitoring external environment data to facilitate adaptation to unanticipated circumstances, such as damaged transportation infrastructures or custom-related challenges (Bak et al., 2023: Polater, 2021). Whilst extant literature has previously indicated that stockouts and stock expiration are more prevalent in public compared to the private HFs in LMICs (Olaniran et al., 2022; Mohan et al., 2024), the current study indicates that these occur more frequently at the low-level HFs which are typically the first point of contact. The study also reveals that an increased presence of shared benefits, SC relationships, adherence to government guidelines, information technology, inventory management and order processing is associated with higher performance in both public and private HCSCs in Uganda, a LMIC.

Tracking stockout and expiration in both public and private HCSCs is consistent with Rodrigues et al. (2004) who recommended tracking stockout at the final consumption point as well as Rodrigues et al. (2004) and Supply-Chain Council (2012) who recommended tracking costs of the SC (including expiration). More frequent stockout and expiration of medicines in the public HCSCs is consistent with Cameron et al (2009) as cited by Kraiselburd and Yadav (2013) who found superior supply chain performance in private compared to the public HCSCs. In the case of Uganda, Namyalo et al. (2025) iterated the challenge of stockouts in public HFs that provided free services. Yet, this study shows that there are differences in the degree of associations between dimensions of collaboration and performance across public and private HCSCs, which is consistent with contingency theory, i.e. the best way to organize depends on the environment to which the organization relates (Scott and Davis, 2015p 127), and Yadav (2015) that management of HCSCs in LMICs is context specific.

According to the study by Polater (2021), the most important capability for identifying solutions to problems in humanitarian SCs is “being collaborative”. The present study has enabled more precise determination of the relationships between different dimensions of collaboration and SC performance. The findings indicated that the presence of shared goals was a catalyst for collaboration, thereby corroborating the findings of Angerhofer and Angelides (2006) and Ralston et al. (2017). The present findings concur with the conclusions of The Global Fund (2017), which emphasized that ineffectiveness of country ownership and governance in LMICs is frequently attributable to an absence of strategic frameworks. This phenomenon results in interventions that are driven by ad-hoc donor requirements rather than coherent national strategies, and provides much needed evidence of the impact of shared goals impact on healthcare improvement in LMICs (Kalaris, 2024).

The study also reveals that public HCSCs, in contrast to the private ones, exhibit an absence of shared benefits for high performance and demonstrate a weak correlation between employee benefits and performance. Nevertheless, the efficacy of last-mile distribution in both public and private HCSCs can be attributed to the utilization of outsourcing. This finding is consistent with the conclusions of Yadav (2015), who determined that a paucity of incentives results in substandard performance in public HCSCs. Finally, the current study reveals that the strategy of contribution of resources exhibits no association with SC performance. Thus, for public HCSCs in LMICs, shared goals and benefits are probable more efficacious strategies to enhance SC performance in comparison to the present strategy of contribution of resources.

Regarding structures for SC collaboration, the current study reveals that overreliance on mandates instead of contracts in public HCSCs weakens SC relationships. This corroborates extant literature that overlapping mandates create ambiguity in responsibility for tasks, which fractures relationships and undermines performance (Yadav, 2015) – a problem exacerbated by the ineffective governance structures that hinder accountability (The Global Fund, 2017). Replacing this model with defined contractual obligations would clarify roles, reduce the need for complex oversight and ultimately strengthen supply chain relationships.

Consistent with Gulati et al. (2012), the current study suggests that SC coordination may be achieved through formal contracts and informal operational rules. The former is consistent with Holt and Ghobadian (2009) who recognized that clear guidelines could lead to common goals within the SC, ultimately boosting performance. The latter is consistent with Friday et al. (2021) who emphasized the importance of alignment of uncertainty and risk perceptions of the different decision-takers on inventory levels along HCSCs.

Regarding systems for SC collaboration, strong associations have been found between the adoption of information technology and performance in both public and private HCSCs, which is consistent with the findings of Angerhofer and Angelides (2006), Miko and Abbas (2024) and Arji et al. (2023). The adoption of emerging technologies such as artificial intelligence, blockchain, drone technology and the Internet of Things has revolutionized many industries and has the potential to enhance the efficiency and responsiveness of complex health supply chains (Singh, 2025). The relatively better performance in private HFs that did not have high levels of information technology and information sharing is consistent with claims by Abdulkadir et al. (2024) and Simchi-Levi et al. (2009) that the benefits which may accrue from adoption of information technology are contingent on existence of appropriate SC practices.

In the context of SC collaboration processes, the absence of fundamental warehousing and inventory management practices such as the maintenance of updated stock records, regular physical counts and medicine tracking for accountability in public HFs is consistent with the findings of Privett and Gonsalvez (2014). These authors identified warehouse management and inventory management among the challenges affecting HCSCs. Surprisingly, private low- and some high-level HFs, even without ERPs, maintained better records and accountability than public counterparts, presumably due to financial incentives.

Reliance on a push system due to a lack of capacity to order in public low-level HFs is consistent with the findings of Privett and Gonsalvez (2014) on order management challenges and Yadav (2015) on the mismatch between skills and system design in HCSCs in LMICs where HF in-charges who are best positioned to order lack the necessary skills. It is therefore vital to strengthening order processing and management if the performance of public HCSCs is to be improved.

Finally, operationalization of healthcare SC processes in LMICs along the established SCOR model is consistent with Lockamy and McCormack (2004); Lambert et al. (2005); Simchi-Levi et al. (2009) and Asrol et al. (2021) in demonstrating the SCOR model as a process framework which helps in measuring and comparing SC performance across sectors in this case public versus private HCSCs.

A framework for SC collaboration has been developed to counter fragmented collaboration practices and enable more effective interventions within the context of public versus private HCSCs in LMICs. Consequently, this paper makes valuable contribution to theory, practice and policy development in this area.

The paper contributes to theory by addressing the call for middle-range theorizing as outlined by Pellathy et al. (2018) and the call for research on collaboration in HCSCs made by Friday et al. (2021), focusing on mechanisms of HCSCs in LMICs. The operationalization of the dimensions of SC collaboration in HCSCs along the established themes of strategy, structure, systems and processes extends the work of Rodrigues et al. (2004). Similarly, operationalization of the SC processes in HCSCs in LMICs along the established SCOR model demonstrates it as a process framework which helps to measure and compare SC performance across sectors, in this case public versus private HCSCs.

Second, this paper contributes to practice by providing a framework of antecedents to improve performance of HCSCs in LMICs. The performance of the public HCSCs in LMICs could be enhanced by benchmarking against the private HCSCs to introduce shared benefits and appropriate SC relationships; promote adherence to government guidelines; adopt and improve existing information technologies as well as improving processes such as warehousing, inventory management and order processing. Recommendations regarding public versus private and high-level versus low-level approaches enable practitioners to deploy the most appropriate set of strategies, structures, systems and processes identified as strongly associated with performance for each situation thereby boosting SC performance with limited resources.

Finally, this paper provides policymakers in the public and private healthcare with a comprehensive framework for SC collaboration, complementing previous fragmented approaches. This framework facilitates development of policies for public HCSCs to benchmark against and leverage best practices of private HCSCs.

This study provides substantial data in the context of Uganda, with a particular focus on two specific medicines: misoprostol and oxytocin. This provides a foundation for future research. To validate generalizability across LMICs, it is recommended that similar investigations be conducted in middle-income countries. Future research directions include the analysis of other medicine types (e.g. those requiring cold chain), the quantitative testing of the proposed framework using models such as Jbaily et al. (2020) and the exploration of how collaboration impacts specific HCSC performance indicators. It is hoped that this study will stimulate further research and promote effective interventions to improve medicine access in LMICs.

Abdulkadir
,
R.
,
Matellini
,
D.B.
,
Jenkinson
,
I.D.
,
Pyne
,
R.
and
Nguyen
,
T.T.
(
2024
), “
Assessing performance using maturity model: a multiple case study of public health supply chains in Nigeria
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
14
No.
1
, pp.
17
-
70
.
Alvargonzález
,
D.
(
2019
), “
Sciences as systems
”,
Perspectives on Science
, Vol.
27
No.
6
, pp.
839
-
860
.
Angerhofer
,
B.J.
and
Angelides
,
M.C.
(
2006
), “
A model and a performance measurement system for collaborative supply chains
”,
Decision Support Systems
, Vol.
42
No.
1
, pp.
283
-
301
.
Arji
,
G.
,
Ahmadi
,
H.
,
Avazpoor
,
P.
and
Hemmat
,
M.
(
2023
), “
Identifying resilience strategies for disruption management in the healthcare supply chain during COVID-19 by digital innovations: a systematic literature review
”,
Informatics in Medicine Unlocked
, Vol.
38
, p.
101199
.
Asrol
,
M.
,
Yani
,
M.
and
Taira
,
E.
(
2021
), “
Risk management for improving supply chain performance of sugarcane agroindustry
”,
Industrial Engineering & Management Systems
, Vol.
20
No.
1
, pp.
9
-
26
.
Bak
,
O.
,
Braganza
,
A.
and
Chen
,
W.
(
2023
), “
Exploring blockchain implementation challenges in the context of healthcare supply chain (HCSC)
”,
International Journal of Production Research
, Vol.
63
No.
2
, pp.
687
-
702
.
Cameron
,
A.
,
Ewen
,
M.
,
Ross-Degnan
,
D.
,
Ball
,
D.
and
Laing
,
R.
(
2009
), “
Medicine prices, availability, and affordability in 36 developing and Middle-income countries: a secondary analysis
”,
The Lancet
, Vol.
373
No.
9659
, pp.
240
-
249
.
Campbell
,
J.L.
,
Quincy
,
C.
,
Osserman
,
J.
and
Pedersen
,
O.K.
(
2013
), “
Coding in-depth semistructured interviews: problems of unitization and intercorder reliability and agreement
”,
Sociological Methods & Research
, Vol.
42
No.
3
, pp.
294
-
320
.
Cao
,
M.
and
Zhang
,
Q.
(
2011
), “
Supply chain collaboration: impact on collaborative advantage and firm performance
”,
Journal of Operations Management
, Vol.
29
No.
3
, pp.
163
-
180
.
Chan
,
M.
(
2018
),
Ten years in public health 2007-2017: Report by
Dr. Margaret Chan, Director-General
.
World Health Organization
.
Chen
,
W.
,
Zhang
,
Z.G.
and
Chen
,
X.
(
2020
), “
On two-tier healthcare system under capacity constraint
”,
International Journal of Production Research
, Vol.
58
No.
12
, pp.
3744
-
3764
.
Chorfi
,
Z.
,
Benabbou
,
L.
and
Berrado
,
A.
(
2018
), “
An integrated performance measurement framework for enhancing public health care supply chains
”,
Supply Chain Forum: An International Journal
, Vol.
19
No.
3
, pp.
191
-
203
.
Chyung
,
S.Y.
,
Roberts
,
K.
,
Swanson
,
I.
and
Hankinson
,
A.
(
2017
), “
Evidence-based survey design: the use of a midpoint on the Likert scale
”,
Performance Improvement
, Vol.
56
No.
10
, pp.
15
-
23
.
Cohen
,
J.
(
1960
), “
A coefficient of agreement for nominal scales
”,
Educational and Psychological Measurement
, Vol.
20
No.
1
, pp.
37
-
46
.
Cresswell
,
J.A.
,
Alexander
,
M.
,
Chong
,
M.Y.
,
Link
,
H.M.
,
Pejchinovska
,
M.
,
Gazeley
,
U.
, …
Say
,
L.
(
2025
), “
Global and regional causes of maternal deaths 2009–20: a WHO systematic analysis
”,
The Lancet Global Health
, Vol.
13
No.
4
, pp.
e626
-
e634
.
Eisenhardt
,
K.M.
(
1989
), “
Building theories from case study research
”,
The Academy of Management Review
, Vol.
14
No.
4
, pp.
532
-
550
.
Flynn
,
B.B.
,
Huo
,
B.
and
Zhao
,
X.
(
2010
), “
The impact of supply chain integration on performance: a contingency and configuration approach
”,
Journal of Operations Management
, Vol.
28
No.
1
, pp.
58
-
71
.
Friday
,
D.
,
Savage
,
D.A.
,
Melnyk
,
S.A.
,
Harrison
,
N.
,
Ryan
,
S.
and
Wechtler
,
H.
(
2021
), “
A collaborative approach to maintaining optimal inventory and mitigating stockout risks during a pandemic: capabilities for enabling health-care supply chain resilience
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
11
No.
2
, pp.
248
-
271
.
Gulati
,
R.
,
Wohlgezogen
,
F.
and
Zhelyazkov
,
P.
(
2012
), “
The two facets of collaboration: cooperation and coordination in strategic alliances
”,
Academy of Management Annals
, Vol.
6
No.
1
, pp.
531
-
583
.
Holt
,
D.
and
Ghobadian
,
A.
(
2009
), “
An empirical study of green supply chain management practices amongst UK manufacturers
”,
Journal of Manufacturing Technology Management
, Vol.
20
No.
7
, pp.
933
-
956
.
Jahre
,
M.
,
Dumoulin
,
L.
,
Greenhalgh
,
L.B.
,
Hudspeth
,
C.
,
Limlim
,
P.
and
Spindler
,
A.
(
2012
), “
Improving health in developing countries: reducing complexity of drug supply chains
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
2
No.
1
, pp.
54
-
84
.
Jbaily
,
A.
,
Feldhaus
,
I.
,
Bigelow
,
B.
,
Kamareddine
,
L.
,
Tolla
,
M.T.
,
Bouvier
,
M.
, …
Verguet
,
S.
(
2020
), “
Toward health system strengthening in low- and Middle-income countries: insights from mathematical modeling of drug supply chains
”,
BMC Health Services Research
, Vol.
20
No.
1
, pp.
1
-
12
.
Kalaris
,
K.W.
(
2024
), “
Developing an understanding of networks in LMIC health systems: how and why networks change practices to improve service delivery and quality of care
”, (Doctoral dissertation,
University of Oxford
).
Kessy
,
S.S.A.
,
Salema
,
G.L.
and
Simwita
,
Y.
(
2024
), “
Lean thinking in medical commodities supply chains: applicability and success factors for Tanzanian health supply chains
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
14
No.
1
, pp.
105
-
117
.
Kraiselburd
,
S.
and
Yadav
,
P.
(
2013
), “
Supply chains and global health: an imperative for bringing operations management scholarship into action
”,
Production and Operations Management
, Vol.
22
No.
2
, pp.
377
-
381
.
Kumar
,
R.
and
Das
,
D.
(
2023
), “
A performance evaluation framework of public health distribution network for essential medicines: lessons from the select Indian states
”,
International Transactions in Operational Research
, Vol.
30
No.
1
, pp.
421
-
452
.
Kwon
,
I.W.
and
Kim
,
S.H.
(
2018
), “
Framework for successful supply chain implementation in healthcare area from provider’s prospective
”,
Asia Pacific Journal of Innovation and Entrepreneurship
, Vol.
12
No.
2
, pp.
135
-
145
.
Ladwar
,
D.O.
,
Sembatya
,
M.N.
,
Amony
,
N.M.
,
Seru
,
M.
,
Ross-Degan
,
D.
,
Garabedian
,
L.
and
Trap
,
B.
(
2021
), (
2021
), “
Impact assessment of supervision performance assessment and recognition strategy (SPARS) to improve supply chain management in health facilities in Uganda: a national pre and post study
”,
Journal of Pharmaceutical Policy and Practice
, Vol.
14
No.
1
, pp.
2
-
15
.
Lambert
,
D.M.
,
Garcia-Dastugue
,
S.J.
and
Croxton
,
K.L.
(
2005
), “
An evaluation of process-oriented supply chain management frameworks
”,
Journal of Business Logistics
, Vol.
26
No.
1
, pp.
25
-
51
.
Liu
,
G.
,
Aroean
,
L.
and
Ko
,
W.W.
(
2022
), “
Power, shared goals and supplier flexibility: a study of the HUB-and-spoke supply chain
”,
International Journal of Operations & Production Management
, Vol.
42
No.
2
, pp.
182
-
205
.
Lockamy
,
A.
and
McCormack
,
K.
(
2004
), “
Linking SCOR planning practices to supply chain performance: an exploratory study
”,
International Journal of Operations & Production Management
, Vol.
24
No.
12
, pp.
1192
-
1218
.
MacPhail
,
C.
,
Khoza
,
N.
,
Abler
,
L.
and
Ranganathan
,
M.
(
2016
), “
Process guidelines for establishing intercoder reliability in qualitative studies
”,
Qualitative Research
, Vol.
16
No.
2
, pp.
198
-
212
.
Mandal
,
S.
and
Jha
,
R.R.
(
2018
), “
Exploring the importance of collaborative assets to hospital-supplier integration in healthcare supply chains
”,
International Journal of Production Research
, Vol.
56
No.
7
, pp.
2666
-
2683
.
Miko
,
N.U.
and
Abbas
,
U.
(
2024
), “
Determinants of efficient last-mile delivery: evidence from health facilities and Kaduna health supplies management agency
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
14
No.
1
, pp.
4
-
16
.
Miles
,
R.E.
,
Snow
,
C.C.
,
Meyer
,
A.D.
and
Coleman
,
H.J.
(
1978
), “
Organizational strategy, structure, and process
”,
Academy of Management Review
, Vol.
3
No.
3
, pp.
546
-
562
.
Ministry of Finance, Planning, and Economic Development, Uganda
(
2024
), “
The budget speech 2024/2025
”,
available at:
Link to The budget speech 2024/2025Link to the cited article.
Ministry of Health, Uganda
(
1993
), “
National medical stores act
”.
Ministry of Health, Uganda
(
2015
), “
The third national pharmaceutical sector strategic plan 2015/16-2019/20
”,
available at:
Link to The third national pharmaceutical sector strategic plan 2015/16-2019/20Link to the cited article.
Ministry of Health, Uganda
(
2016
), “
Uganda health facility inventory
”.
Ministry of Health, Uganda
(
2017
a), “
Facility tracer medicines stock status reports
”,
available at:
Link to Facility tracer medicines stock status reportsLink to the cited article.
Ministry of Health, Uganda
(
2017
b), “
The annual health sector performance report 2016/17
”,
available at:
Link to The annual health sector performance report 2016/17Link to the cited article.
Ministry of Health, Uganda
(
2017
c), “
Essential medicines and health supplies management manual of Uganda
”.
Ministry of Health, Uganda
(
2020
), “
Annual health sector performance report financial year 2019/2020
”.
Mohamed
,
A.E.
and
Huynh
,
K.T.A.
(
2023
), “
Mitigating the bullwhip effect and enhancing supply chain performance through demand information sharing: an ARENA simulation study
”,
Journal of Economics and Sustainable Development
, Vol.
14
No.
14
, pp.
78
-
165
.
Mohan
,
S.
,
Mangal
,
T.D.
,
Colbourn
,
T.
,
Chalkley
,
M.
,
Chimwaza
,
C.
,
Collins
,
J.H.
, …
Hallett
,
T.B.
(
2024
), “
Factors associated with medical consumable availability in level 1 facilities in Malawi: a secondary analysis of a facility census
”,
The Lancet Global Health
, Vol.
12
No.
6
, pp.
e1027
-
e1037
.
Mutebi
,
H.
,
Ntayi
,
J.M.
,
Muhwezi
,
M.
and
Munene
,
J.C.K.
(
2020
), “
Self-organisation, adaptability, organisational networks and inter-organisational coordination: empirical evidence from humanitarian organisations in Uganda
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
10
No.
4
, pp.
447
-
483
.
Namagembe
,
S.
(
2020
), “
Enhancing service delivery in humanitarian relief chains: the role of relational capital
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
10
No.
2
, pp.
169
-
203
.
Namyalo
,
P.K.
,
Chadambuka
,
C.
,
Forman
,
L.
,
Essue
,
B.M.
and
Ssengooba
,
F.
(
2025
), “
Exploring the facilitators and barriers to achieving universal health coverage in Uganda: a qualitative study of the free healthcare policy
”,
Health Research Policy and Systems
, Vol.
23
No.
1
, pp.
60
-
76
.
Olalekan
,
A.
,
Igweike
,
V.
,
Ekun
,
O.
,
Adegbite
,
A.
and
Ogunleye
,
O.
(
2024
), “
Assessment of pre-eclampsia and eclampsia health commodities’ supply chains in selected hospitals of Lagos state during COVID-19 pandemic
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
14
No.
1
, pp.
71
-
81
.
Olaniran
,
A.
,
Briggs
,
J.
,
Pradhan
,
A.
,
Bogue
,
E.
,
Schreiber
,
B.
,
Dini
,
H.S.
, …
Ballard
,
M.
(
2022
), “
Stock-outs of essential medicines among community health workers (CHWs) in low-and Middle-income countries (LMICs): a systematic literature review of the extent, reasons, and consequences
”,
Human Resources for Health
, Vol.
20
No.
1
, pp.
58
-
68
.
Onyango
,
J.O.
(
2024
), “
Supply chain solutions for essential medicine availability during COVID-19 pandemic
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
14
No.
1
, pp.
118
-
133
.
Pellathy
,
D.A.
,
In
,
J.
,
Mollenkopf
,
D.A.
and
Stank
,
T.P.
(
2018
), “
Middle-range theorizing on logistics customer service
”,
International Journal of Physical Distribution & Logistics Management
, Vol.
48
No.
1
, pp.
2
-
18
.
Polater
,
A.
(
2021
), “
Dynamic capabilities in humanitarian supply chain management: a systematic literature review
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
11
No.
1
, pp.
46
-
80
.
Privett
,
N.
and
Gonsalvez
,
D.
(
2014
), “
The top ten global health supply chain issues: perspectives from the field
”,
Operations Research for Health Care
, Vol.
3
No.
4
, pp.
226
-
230
.
Ralston
,
P.M.
,
Richey
,
R.G.
and
Grawe
,
S.J.
(
2017
), “
The past and future of supply chain collaboration: a literature synthesis and call for research
”,
The International Journal of Logistics Management
, Vol.
28
No.
2
, pp.
508
-
530
.
Ramanathan
,
R.
and
Ramanathan
,
U.
(
2011
), “
A performance measurement framework combining DEA and balanced scorecard for the UK health sector
”,
International Journal of Operational Research
, Vol.
12
No.
3
, pp.
257
-
278
.
Ribeiro
,
D.P.
,
De Oliveira
,
U.R.
,
da Silva César
,
A.
and
Aprigliano Fernandes
,
V.
(
2021
), “
Evaluation of medicine reverse logistics practices in hospitals
”,
Sustainability
, Vol.
13
No.
6
, p.
3496
.
Rodrigues
,
A.M.
,
Stank
,
T.P.
and
Lynch
,
D.F.
(
2004
), “
Linking strategy, structure, process and performance in integrated logistics
”,
Journal of Business Logistics
, Vol.
25
No.
2
, pp.
65
-
94
.
Romule
,
K.
,
Bak
,
O.
,
Colicchia
,
C.
and
Shaw
,
S.
(
2020
), “
Supplier performance assessment: evidence from a UK-based manufacturing company and its suppliers
”,
Benchmarking: An International Journal
, Vol.
27
No.
2
, pp.
817
-
838
.
Rugumambaju
,
S.
, and
Kutyabami
,
P.
(
2010
),
Pharmaceutical Sector Profile: Uganda
,
United Nations Industrial Development Organization
,
Vienna
.
Scott
,
W.R.
, and
Davis
,
G.F.
(
2015
),
Organizations and Organizing: Rational, Natural and Open Systems Perspective
,
Routledge
,
New York, NY
.
Simchi-Levi
,
D.
,
Kaminsky
,
P.
, and
Simchi-Levi
,
E.
(
2009
),
Designing and Managing the Supply Chain: Concepts, Strategies and Case Studies
, ( (3rd) ed.).
McGraw-Hill
,
New York, NY
.
Singh
,
R.K.
(
2025
), “
Leveraging technology in humanitarian supply chains: impacts on collaboration, agility and sustainable outcomes
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
15
No.
2
, pp.
61
-
73
.
Stulens
,
S.
,
DeBoeck
,
K.
and
Vandaele
,
N.
(
2021
), “
HIV supply chains in low- and Middle-income countries: overview and research opportunities
”,
Journal of Humanitarian Logistics and Supply Chain Management
, Vol.
11
No.
3
, pp.
369
-
401
.
Supply-Chain Council
(
2012
), “
Supply-Chain operations reference-model: overview of SCOR version 11.0
”.
The Global Fund
(
2017
), “
Audit report: the global fund’s in-country supply chain processes
”,
available at:
Link to Audit report: the global fund’s in-country supply chain processesLink to the website of..]
Tukamuhabwa
,
B.
,
Stevenson
,
M.
and
Busby
,
J.
(
2017
), “
Supply chain resilience in a developing country context: a case study on the interconnectedness of threats, strategies and outcomes
”,
Supply Chain Management: An International Journal
, Vol.
22
No.
6
, pp.
486
-
505
.
Uganda Bureau of Statistics
(
2024
),
The National Population and Housing Census 2024 - Preliminary Report
.
Vijayasarathy
,
L.R.
(
2010
), “
Supply integration: an investigation of its multi-dimensionality and relational antecedents
”,
International Journal of Production Economics
, Vol.
124
No.
2
, pp.
489
-
505
.
Vollmann
,
T.E.
(
1996
),
The Transformation Lmperative
,
Harvard Business School Press
,
Boston, MA
.
Wagner
,
J.A.
III
, (
2025
), “
Dimensional research on organization structure: meta-analysis and conceptual redirection
”,
Journal of Management & Organization
, Vol.
31
No.
4
, pp.
1854
-
1871
. (2025).
WHO
(
2012
),
WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage
,
WHO
,
Geneva
.
WHO
(
2022
), “
Points to consider for setting the remaining shelf-life of medical products upon delivery
”,
available at:
Link to Points to consider for setting the remaining shelf-life of medical products upon deliveryLink to the cited article.
Wirtz
,
V.J.
,
Hogerzeil
,
H.V.
,
Gray
,
A.L.
,
Bigdeli
,
M.
,
Joncheere
,
C.P.
,
Ewen
,
M.A.
, …
Rashidian
,
A.
(
2016
), “
Essential medicines for universal health coverage
”,
The Lancet
, Vol.
389
No.
10067
, pp.
403
-
476
.
Yadav
,
P.
(
2015
), “
Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform
”,
Health Systems & Reform
, Vol.
1
No.
2
, pp.
142
-
154
.
Yin
,
R.K.
(
2014
),
Case Study Research: Design and Methods
, ( (3rd) ed.).
Sage
,
Thousand Oaks
.
Auditor General of Uganda
(
2021
), “
Report of the auditor general to parliament for the financial year ended 30th June 2020
”,
Office of the Auditor General.
Vogtländer
,
J.G.
and
Bijma
,
A.
(
2000
), “
The virtual polition prevention costs “99”, a single LCA-based indicator for emissions
”,
Lnternational Journal of LGA
, Vol.
5
No.
2
, pp.
113
-
124
.
  1. How has been the supply of medicines to your facility. Probe for information on Misoprostol and Oxytocin.

  2. Refer to the graphs (focusing devices) on stock levels of Misoprostol and Oxytocin. Are the graphs accurate? What happened during that period?

  3. Can you recall a major incident when the flow of products, information, money, or decisions in the selected supply chain was disrupted? If yes,

    • What products, information, money, or decisions were involved?

    • When did the disruption occur?

    • Where did the disruption occur?

    • Who was responsible for the disruption?

    • What incidents preceded the disruption?

  4. Can you recall a major stock-out of essential medicines? If yes,

    • What essential medicines had stock-out?

    • When did the stock-out occur?

    • Where did they stock-out occur?

    • Who was responsible for the stock-out?

    • What incidents preceded the stock-out?

  5. Can you recall a major expiration of essential medicines? If yes,

    • What essential medicines expired?

    • When did the expiration occur?

    • Where did the expiration occur?

    • Who was responsible for the expiration?

    • What incidents preceded the expiration?

  6. What are the strategic supply chain related objectives of your organization?

  7. What are the supply chain related Key Performance Indicators (KPIs) of your organization?

  8. How do you coordinate with other members of your supply chain?

  9. What rules govern your supply chain operations?

Source(s): Authors’ own work

Table A1

List of key informants

Supply chainHF levelCaseQualification
PNFPHigh levelCase 2aPharmacist
GovtHigh levelCase 1aHF in-charge (nurse)
PNFPLow levelCase 2bHF in-charge (nurse)
GovtLow levelCase 1bHF in-charge (nurse)
PNFPLow levelCase 2bHF in-charge (nurse)
GovtHigh levelCase 1aPharmacist
Cross cuttingCross cuttingCross cuttingDADI (pharmacy technician)
PNFPHigh levelCase 2aPharmacist
PNFPHigh levelCase 2aPharmacist
PNFPHigh levelCase 2aPharmacist
GovtHigh levelCase 1aPharmacist
GovtHigh levelCase 1aPharmacist
Cross cuttingCross cuttingCross cuttingDMMS (pharmacy technician)
PNFPHigh levelCase 2aPharmacist
Cross cuttingCross cuttingCross cuttingDMMS (pharmacy technician)
GovtHigh levelCase 1aPharmacy technician
Cross cuttingCross cuttingCross cuttingDistrict store in-charge (diploma in business)
GovtHigh levelCase 1aPharmacy technician
PNFPHigh levelCase 2aPharmacist
GovtHigh levelCase 1aPharmacist
GovtLow levelCase 1bHF in-charge (nurse)
PNFPHigh levelCase 2aHF in-charge (nurse)
GovtHigh levelCase 1aStores officer
PNFPLow levelCase 2 bHF in-charge (nurse)
PNFPHigh levelCase 2aStores in-charge (diploma in business)
PNFPLow levelCase 2 bHF in-charge (nurse)
GovtHigh levelCase 1aStores in-charge (diploma in business)
GovtCross cuttingCase 1a and 1bPharmacist
Cross cuttingCross cuttingCross cuttingPharmacy technician
Cross cuttingCross cuttingCross cuttingPharmacist
Cross cuttingCross cuttingCross cuttingDMMS (pharmacy technician)
Cross cuttingCross cuttingCross cuttingProject staff (pharmacist)
Cross cuttingCross cuttingCross cuttingDMMS (pharmacy technician)
PNFPCross cuttingCase 2a and 2bPharmacist
Cross cuttingCross cuttingCross cuttingChief of party (pharmacist)
Cross cuttingCross cuttingCross cuttingNPO (pharmacist)
Cross cuttingCross cuttingCross cuttingACHS (pharmacy)
GovtLow levelCase 1bHF in-charge (nurse)
Cross cuttingCross cuttingCross cuttingNational professional staff (midwife)
Source(s): Authors’ own work
Table A2

Code book

NameDescription
1. Strategies for collaborationHigh level code not to be used for direct coding. Use its lower-level codes instead
1.1 Shared objectivesThe role of congruency of supply chain related objectives among the different supply chain members
1.2 Contribution of resourcesPooling of resources to finance the supply chain
1.3 Shared benefits (incentives)Includes incentives - the financial incentives or other benefits that accrue from appropriate supply chain performance that will motivate an individual or organization
2. Structures for collaborationHigh level code not to be used for direct coding. Use its lower-level codes instead
2.1 Coordinating InstitutionsOrganizations set up to ensure that the SC members work in harmony to deliver health products
2.2 SC relationshipsThe way SC members relate to enhance SC collaboration including alliances, partnerships and cooperation’s
2.3 Coordinating committeesCommittees to coordinate logistics and supply chain work
2.4 GuidelinesThe existence of and adherence to guidelines in implementation and operation of supply chains and health services. Includes guidelines for introduction of new commodities
2.4.1 Clinical useExistence and adherence to guidelines on clinical use to dispel myths and misconceptions that lead to under use or overuse of a commodity
2.4.2 Logistics managementThe existence and adherence to guidelines on logistics management including donations, ordering, supplying, etc
2.4.3 Services providedExistence and adherence to service provision guidelines specifying health facility level and services provided
3. Systems for collaborationHigh level code not to be used for direct coding. Use its lower-level codes instead
3.1 Information systemsHigh level code not to be used for direct coding. Use its lower-level codes instead
3.1.1 Information TechnologyThe role of Information Technology including systems like LMIS, ordering systems, warehouse management systems; Includes routine health information systems, Information Technology like EDI and sharing of platforms improve information quality by eliminating data entry errors while facilitating information sharing (Simchi-Levi et al., 2009)
3.1.2 Information sharingInformation sharing enables members of the supply chain to use Point of Sale (POS) data to arrive at more accurate demand forecasts and agree on the production and supply plans that achieve global optimization of the supply chain as opposed to the less effective local optimization which disregards the effect of one member’s decisions on the rest of the supply chain (Simchi-Levi et al., 2009)
3.2 Performance measurement systems
3.2.1 Performance Indicators (KPIs)The role of KPIs agreed among the different supply chain members as a measure of how well their supply chain is functioning
3.2.2 Joint performance monitoringIncludes joint monitoring of implementation of agreed SC actions and performance
4. Collaboration processesSCOR model processes include planning, purchasing/sourcing, making, delivery (includes storage and distribution) and returning
4.1 Plan (demand forecast and supply plan)The process of demand forecasting, budget allocation and supply planning - How is the decision made? Who makes the decision?
4.2 Source (Procurement)Process of acquisition of products in line with demand forecast and budget
4.3 Source (warehousing and inventory management)The provision of storage within country at central level and subnational levels. Includes cold chain storage facilities
4.4 Delivery (order processing and last mile distribution)The movement of products from central level storage to subnational storage points including the last mile (from subnational storage point to service delivery point)
4.5 Product return (redistribution)Includes reverse logistics - the movement of product from places where it may not be consumed to places where there is high demand to prevent stock accumulation. Includes return of viable stock to the lead supply chain agency
5. Supply chain performanceHigh level code not to be used for direct coding. Use its lower-level codes instead
5.1 Flow (of products, finances and demand forecasts)Uninterrupted flow of products, finances and demand forecasts as a precursor to optimal supply chain performance
5.2 StockoutsThe phenomenon of stockout; occurrence, consequences and responses by those affected
5.3 Stock accumulationIncludes the phenomenon of stock accumulation; its occurrence, consequences and responses by those affected
5.4 Stock expirationThe phenomenon of stock expiration; its occurrence, consequences and responses by those affected
Source(s): Authors’ own work
Table A3

Uganda: Association of strategies for SC collaboration with performance of public versus private health supply chains

Strategies for SC collaborationPublic HFsPrivate HFs
High level HFsShared goals+++−−
Contribution of resources (budgeting and financing)−−’−−−
Shared benefits (incentives)+++++
Low level HFsShared goals++−−
Contribution of resources (budgeting and financing)−−’−−−
Shared benefits (incentives)++++++
Source(s): Authors’ own work
Table A4

Uganda: Association of structures for SC collaboration with performance of public versus private health supply chains

Structures for SC collaborationPublic HFsPrivate HFs
High level HFsCoordinating institutions+++−−−
SC relationships+++’++
Coordinating committees+++−−−
Guidelines on clinical use++++
Guidelines on logistics management+++++
Guidelines on services provided+++++
Low level HFsCoordinating institutions++−−
SC relationships++’++
Coordinating committees+++−−
Guidelines on clinical use++++++
Guidelines on logistics management+++++
Guidelines on services provided+++++
Source(s): Authors’ own work
Table A5

Uganda: Association of systems for SC collaboration with performance of public versus private health supply chains

Systems for SC collaborationPublic HFsPrivate HFs
High level HFsInformation technology+++++
Information sharing++’−−
Joint key performance indicators (KPIs)+++−−−
Joint performance monitoring+++−−−
Low level HFsInformation technology+++−−
Information sharing+++’−−
Joint key performance indicators (KPIs)+++−−
Joint performance monitoring+++−−
Source(s): Authors’ own work
Table A6

Associations of SC collaboration processes with performance of public versus private health supply chains

SC collaboration processesPublic HFsPrivate HFs
High level HFsPlanning (demand forecast and supply plan)+++−−
Source (procurement)−−’+++
Source (warehousing and inventory management)+++++
Product delivery (order processing)++++++
Product delivery (last mile distribution)−−+++
Product return (redistribution)−−−−
Low level HFsPlanning (demand forecast and supply plan)++++
Source (procurement)−−’++
Source (warehousing and inventory management)+++++
Product delivery (order processing)+++++
Product delivery (last mile distribution)---++
Product return (redistribution)−−−−−
Source(s): Authors’ own work
Published by Emerald Publishing Limited. This article is published under the Creative Commons Attribution (CC BY 4.0) licence. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this licence may be seen at Link to the terms of the CC BY 4.0 licenceLink to the terms of the CC BY 4.0 licence.

or Create an Account

Close Modal
Close Modal